medric medric
잠시만 기다려 주세요. 로딩중입니다.

Humanin suppresses receptor activator of nuclear factor-κB ligand-induced osteoclast differentiation via AMP-activated protein kinase activation

Korean Journal of Physiology & Pharmacology 2019년 23권 5호 p.411 ~ 417
 ( Kang Nam-Ju ) - Yonsei University College of Dentistry Department of Oral Biology

 ( Kim Ki-Woo ) - Yonsei University College of Dentistry Department of Oral Biology
 ( Shin Dong-Min ) - Yonsei University College of Dentistry Department of Oral Biology


Humanin (HN) is a mitochondrial peptide that exhibits cytoprotective actions against various stresses and diseases. HN has been shown to induce the phosphorylation of AMP-activated protein kinase (AMPK), which is a negative regulator of receptor activator of nuclear factor-κB ligand (RANKL). However, the role of HN in osteoclastogenesis or other skeletal disorders remains unknown. Here, we examined whether HN regulates osteoclastogenesis via AMPK activation using bone marrow-derived macrophage (BMM) cultures. Our results show that HN inhibited RANKL-induced osteoclast formation and reduced the expression of genes involved in osteoclastogenesis, including nuclear factor of activated T-cells cytoplasmic 1, osteoclast-associated receptor, cathepsin K, and tartrate-resistant acid phosphatase. Moreover, HN increased the levels of phosphorylated AMPK protein; compound C, an AMPK inhibitor, recovered HN-induced osteoclast differentiation. In addition, we found that HN significantly decreased the levels of RANKL-induced reactive oxygen species in BMMs. Therefore, these results indicate that HN plays an important role in osteoclastogenesis and may function as an inhibitor of bone disorders via AMPK activation.


AMP-activated protein kinase; Humanin; Osteoclastogenesis; Receptor activator of nuclear factor-κB; ligand
원문 및 링크아웃 정보
등재저널 정보